Ambulatory arrhythmia monitoring: Choosing the right device

Circulation

Volumn 122, Issue 16, 2010, Pages 1629-1636

  Zimetbaum, Peter ^a   Goldman, Alena ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

ABLATION THERAPY; AMBULATORY MONITORING; BRADYCARDIA; DEFIBRILLATOR; DEVICE THERAPY; ELECTROCARDIOGRAPHY MONITORING; ELECTRODE; HEALTH CARE COST; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FAILURE; HEART PALPITATION; HEART RHYTHM; HOLTER MONITORING; HUMAN; IMPLANT; IMPLANTABLE LOOP RECORDER; MOBILE PHONE; PRIORITY JOURNAL; REVIEW; SINUS NODE DYSFUNCTION; SUDDEN DEATH; SYNCOPE; TACHYCARDIA; TELEMETRY; TREATMENT REFUSAL; ARTIFICIAL HEART PACEMAKER; ELECTROCARDIOGRAPHY; INSTRUMENTATION; MONITORING; PATHOPHYSIOLOGY;

ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; HUMANS; MONITORING, PHYSIOLOGIC; PACEMAKER, ARTIFICIAL;

EID: 78049524845     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.925610     Document Type: Review

References (34)

1. Buckles D, Aguel F, Brockman R, Cheng J, Demian C, Ho C, Jensen D, Mallis E. Advances in ambulatory monitoring: regulatory considerations. J Electrocardiol. 2004;37(suppl): 65-67.
2. Holter NJ. New method for heart studies: continuous electrocardiography of active subjects over long periods is now practical. Science. 1961;134:1214-1220.
3. Zimetbaum PJ, Josephson ME. The evolving role of ambulatory arrhythmia monitoring in general clinical practice. Ann Intern Med. 1999;130:848-856.
4. Vasamreddy CR, Dalal D, Dong J, Cheng A, Spragg D, Lamiy SZ, Maininger G, Henrikson CA, Marine JE, Berger R, Calkins H. Symptomatic and asymptomatic atrial fibrillation in patients undergoing radiofrequency catheter ablation. J Cardiovasc Electrophysiol. 2006;17:134-139.
5. Hauser TH, Pinto DS, Josephson ME, Zimetbaum P. Safety and feasibility of a clinical pathway for the outpatient initiation of antiarrhythmic medications in patients with atrial fibrillation or atrial flutter. Am J Cardiol. 2003;91:1437-1441.
6. Douen A, Pageau N, Medic S. Usefulness of cardiovascular investigation in stroke management: clinical relevance and economic implications. Stroke. 2007;38:1956-1958.
7. Liao J, Khalid Z, Scallan C, Morillo C, O'Donnell M. Non-invasive cardiac monitoring for detecting of paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review. Stroke. 2007;38:2935-2940.
8. Gula LJ, Krahn AD, Massel D, Skanes A, Yee R, Klein GJ. External loop recorders: determinants of diagnostic yield in patients with syncope. Am Heart J. 2004;147:644-648.
9. Gottipaty VK, Khoury L, Beard JT, Hamson V. A novel real-time ambulatory cardiac monitoring system is user-friendly and effective for identifying cardiac arrhythmias: clinical studies [abstract]. Columbia, SC: Biowatch Medical, Inc; 2008.
10. Joshi AK, Kowey PR, Prystowsky EN, Benditt DG, Cannom DS, Pratt CM, McNamara A, Sangrigoli RM. First experience with a Mobile Cardiac Outpatient Telemetry (MCOT) system for the diagnosis and management of cardiac arrhythmia. Am J Cardiol. 2005;95:878-881.
11. Rothman SA, Laughlin JC, Seltzer J, Walia JS, Baman RI, Siouffi SY, Sangrigoli RM, Kowey PR. The diagnosis of cardiac arrhythmias: a prospective multi-center randomized study comparing mobile cardiac outpatient telemetry versus standard loop event monitoring. J Cardiovasc Electrophysiol. 2007;18:241-247.
12. Glotzer T, Hellkamp A, Zimmerman J, Sweeney M, Yee R, Marinchak R, Cook J, Paraschos A, Love J, Radoslovich G, Lee KL, Lamas GA. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke. Circulation. 2003;107:1614-1619.
13. Zimetbaum PJ, Kim KY, Josephson ME, Goldberger AL, Cohen DJ. Diagnostic yield and optimal duration of continuous-loop event monitoring for the diagnosis of palpitations. Ann Intern Med. 1998;128:890-895.
14. Kinlay S, Leitch JW, Neil A, Chapman BL, Hardy DB, Fletcher PJ. Cardiac event recorders yield more diagnoses and are more costeffective than 48-hour Holter monitoring in patients with palpitations. Ann Intern Med. 1996;124:16-20.
15. Fogel RI, Evans JJ, Prystowsky EN. Utility and cost of event recorders in the diagnosis of palpitations, presyncope and syncope. Am J Cardiol. 1997;79:207-208.
16. Giada F, Gulizia M, Francese M, Croci F, Santangelo L, Santomauro M, Occhetta E, Menozzi C, Raviele A. Recurrent unexplained palpitations (RUP) study: comparison of implantable loop recorder versus conventional diagnostic strategy. J Am Coll Cardiol. 2007;49:1951-1956.
17. DiMarco JP, Philbrick JT. Use of ambulatory electrocardiographic (Holter) monitoring. Ann Intern Med. 1990;113:53-68.
18. Bass EB, Curtiss EI, Arena VC, Hanusa BH, Cecchetti A, Karpf M, Kapoor WN. The duration of Holter monitoring in patients with syncope: is 24 hours enough? Arch Intern Med. 1990;150:1073-1078.
19. Sivakumaran S, Krahn AD, Klein GJ, Finan J, Yee R, Renner S, Skanes AC. A prospective randomized comparison of loop recorders versus Holter monitors in patients with syncope or presyncope. Am J Med. 2003;115:1-5.
20. Krahn AD, Klein GJ, Norris C, Yee R. The etiology of syncope in patients with negative tile table and electrophysiological testing. Circulation. 1995;92:1819-1824.
21. Krahn AD, Klein GJ, Skanes AC, Yee R. Use of implantable loop recorder in evaluation of patients with unexplained syncope. J Cardiovasc Electrophysiol. 2003;14(suppl): S70-S73.
22. Krahn AD, Klein GJ, Yee R, Norris C. Final results from a pilot study with an implantable loop recorder to determine the etiology of syncope in patients with negative noninvasive and invasive testing. Am J Cardiol. 1998;82:117-119.
23. Farwell DJ, Freemantle N, Sulke N. Clinical impact of implantable loop recorders in patients with syncope. Eur Heart J. 2006;27:351-356.
24. Krahn AD, Klein GJ, Yee R, Manda V. The high cost of syncope: cost implications of a new insertable loop recorder in the investigation of recurrent syncope. Am Heart J. 1999;135:870-877.
25. Nierop PR, van Mechelen R, van Elsäcker A, Luijten RH, Elhendy A. Heart rhythm during syncope and presyncope: results of implantable loop recorders. Pacing Clin Electrophysiol. 2000;23:1532-1538.
26. Crawford MH, Bernstein SJ, Deedwania PC, DiMarco JP, Ferrick KJ, Garson A Jr, Green LA, Greene HL, Silka MJ, Stone PH, Tracy CM, Gibbons RJ, Alpert JS, Eagle KA, Gardner TJ, Gregoratos G, Russell RO, Ryan TH, Smith SC Jr. ACC/AHA guidelines for ambulatory electrocardiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 1999;34:912-948.
27. Hanke T, Charitros E, Stierle U, Karluss A, Kraatz E, Graf B, Hagemann A, Misfeld M, Sievers H. Twenty-four hour Holter monitor follow-up does not provide accurate heart rhythm status after surgical atrial fibrillation therapy: up to 12 months experience with a novel permanently implantable heart rhythm monitor device. Circulation. 2009;120(suppl): S177-S184.
28. Pontoppidan J, Nielsen JC, Poulsen SH, Hansen PS. Symptomatic and asymptomatic atrial fibrillation after pulmonary vein ablation and the impact on quality of life. Pacing Clin Electrophysiol. 2009;32:717-726.
29. Capucci A, Santini M, Padeletti L, Gulizia M, Botto G, Boriani G, Ricci R, Favale S, Zolezzi F, Belardino N, Molon G, Drago F, Villani G, Mazzini E, Vimercati M, Grammatico A. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol. 2005;146:1913-1920.
30. Glotzer T, Daoud E, Wyse G, Singer D, Ezekowitz M, Hilker C, Miller C, Qi D, Ziegler P. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk. Circ Arrhythmia Electrophysiol. 2009;2:474-480.
31. Ip J, Waldo A, Lip G, Rothwell P, Martin D, Barsohn M, Choucair W, Akar J, Wather M, Rohani P, Halperin J. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: rationale, design, and clinical characteristics of the initially enrolled cohort: the IMPACT Study. Am Heart J. 2009;158:364-370.
32. Krahn AD, Klein GJ, Yee R, Hoch JS, Skanes AC. Cost implications of testing strategy in patients with syncope: randomized assessment of syncope trial. J Am Coll Cardiol. 2003;42:502-504.
33. Raatikainen M, Uusimaa P, van Ginneken MM, Jannsen JP, Linnaluoto M. Remote monitoring of implantable cardioverter defibrillator patients: a safe, time saving, and cost effective means for follow-up. Europace. 2008;10:1145-1151.
34. Varma N. Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST). Am Heart J. 2007;154:1029-1034.